Project Grant R01DK137868
Award Date
8/1/24
Completion Date
5/31/27
Dollars Obligated
$667K
Awardee
Mayo Clinic (Y2K4F9RPRRG7)
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Rochester, MN 55905, USA
Similar Awards
This Project Grant award of $488,920.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will support research conducted by Dr. Djibril M. Ba at the Pennsylvania State University's Milton S. Hershey Medical Center. The project aims to prospectively determine the role of dietary patterns in the development of diabetes or pre-diabetes following acute pancreatitis, as well...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $2,063,777 Project Grant (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) to the University of Colorado-Denver to conduct a 24-month, randomized, placebo-controlled, double-blind clinical trial evaluating the efficacy, safety, and mechanisms of a glucagon-like peptide-1 receptor agonist (GLP-1RA) in slowing kidney disease progression in 126 adults with autosomal dominant...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports a $306,994 pilot clinical trial to assess the safety, compliance, and efficacy of a soy-tomato dietary intervention in reducing inflammation and improving outcomes for individuals with chronic pancreatitis. The primary objectives are to: 1) Conduct a pilot clinical trial to demonstrate the tolerability and...
This Project Grant award of $1,349,491 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research at the University of Pennsylvania to investigate the role of the enzyme GPT2 in pancreatic beta cell dysfunction and death associated with type 2 diabetes. The research aims to elucidate the mechanisms by which GPT2 impacts beta cell metabolism, function, and sensitivity to the incretin...
This federal Project Grant award of $577,694 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to investigate the mechanisms underlying Type 3C diabetes (T3CD) associated with exocrine pancreas diseases like chronic pancreatitis and pancreatic ductal adenocarcinoma. The key objectives are to: 1) study gene regulation and electrophysiology in primary human islet cells from subjects with...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $614,420 Project Grant (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) to the Hennepin Healthcare Research Institute (HHRI) to evaluate the effectiveness of the Diabetes Homeless Medication Support (D-HOMES) program. The D-HOMES program provides behavioral support and referrals to community resources to improve medication adherence and glycemic control among adults with type 2...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $808,866.00 to Progenra Inc. to evaluate novel small molecule activators of the ubiquitin proteasome system (UPS) for their efficacy in cellular and animal models of acute and chronic pancreatitis. The goal is to develop these UPS activators as potential therapeutic drugs to treat pancreatitis, a major health...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Emory University a 5-year, $555,034 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will fund the "Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation (CARE-D-FOOT-NAV)" randomized controlled trial. The project aims to assess the effectiveness of a patient navigator program in improving diabetic foot ulcer...
The University of Pittsburgh received a $396,750 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, effective September 1, 2024 and running through June 30, 2028, will fund research to investigate the mechanisms underlying liver injury caused by the anti-leukemia drug pegylated asparaginase (PEG-ASNASE). The key objectives of the research are...
This $1,549,414 Project Grant, awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research, aims to improve the validity of linked real-world data studies for diabetes mellitus research. The study, titled "IMPROVING THE VALIDITY OF LINKED REAL-WORLD DATA STUDIES FOR DIABETES MELLITUS RESEARCH (VALIDATE-DM)", will focus on developing systematic approaches to investigate potential...